These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


103 related items for PubMed ID: 8243628

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Binding characteristics of a new 1,5-benzothiazepine, clentiazem, to rat cerebral cortex and skeletal muscle membranes.
    Suzuki T, Kurosawa H, Naito K, Otsuka M, Ohashi M, Takaiti O.
    Eur J Pharmacol; 1991 Mar 05; 194(2-3):195-200. PubMed ID: 2060600
    [Abstract] [Full Text] [Related]

  • 5. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies.
    Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H.
    J Biol Chem; 1990 Jan 05; 265(1):363-70. PubMed ID: 2152924
    [Abstract] [Full Text] [Related]

  • 6. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
    Staudinger R, Knaus HG, Glossmann H.
    J Biol Chem; 1991 Jun 15; 266(17):10787-95. PubMed ID: 1645709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel.
    Shimasue K, Urushidani T, Hagiwara M, Nagao T.
    Eur J Pharmacol; 1996 Feb 05; 296(3):347-50. PubMed ID: 8904088
    [Abstract] [Full Text] [Related]

  • 11. High-affinity binding of [3H]DTZ323 to the diltiazem-binding site of L-type Ca2+ channels.
    Hagiwara M, Adachi-Akahane S, Nagao T.
    Eur J Pharmacol; 2003 Apr 11; 466(1-2):63-71. PubMed ID: 12679142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Is Ca2+ antagonists binding protein from cytosolic fraction the precursor of alpha 1-subunit of Ca2+ channel?
    Krizanová O, Hudecová S, Orlický J, Zachar J.
    Gen Physiol Biophys; 1989 Apr 11; 8(2):99-111. PubMed ID: 2550315
    [Abstract] [Full Text] [Related]

  • 16. Identification of binding sites for calcium channel antagonists.
    Nakayama H, Kuniyasu A.
    Jpn Heart J; 1996 Sep 11; 37(5):643-50. PubMed ID: 8973377
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    Schoemaker H, Langer SZ.
    J Pharmacol Exp Ther; 1989 Feb 11; 248(2):710-5. PubMed ID: 2537412
    [Abstract] [Full Text] [Related]

  • 19. Allosteric interaction of semotiadil fumarate, a novel benzothiazine, with 1,4-dihydropyridines, phenylalkylamines, and 1,5-benzothiazepines at the Ca(2+)-channel antagonist binding sites in canine skeletal muscle membranes.
    Nakayama K, Nozawa Y, Fukuta Y.
    J Cardiovasc Pharmacol; 1994 May 11; 23(5):731-40. PubMed ID: 7521455
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.